X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Panacea Biotech with FDC LTD. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs FDC LTD. - Comparison Results

PANACEA BIOTECH    Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH FDC LTD. PANACEA BIOTECH/
FDC LTD.
 
P/E (TTM) x 80.7 17.3 465.7% View Chart
P/BV x 1.8 3.6 49.6% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 PANACEA BIOTECH   FDC LTD.
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-14
FDC LTD.
Mar-14
PANACEA BIOTECH/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs149144 103.6%   
Low Rs8279 104.2%   
Sales per share (Unadj.) Rs84.147.6 176.9%  
Earnings per share (Unadj.) Rs-18.37.6 -240.6%  
Cash flow per share (Unadj.) Rs-6.79.0 -74.3%  
Dividends per share (Unadj.) Rs02.25 0.0%  
Dividend yield (eoy) %02.0 0.0%  
Book value per share (Unadj.) Rs83.747.5 176.1%  
Shares outstanding (eoy) m61.25177.83 34.4%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x1.42.3 58.7%   
Avg P/E ratio x-6.314.6 -43.2%  
P/CF ratio (eoy) x-17.212.3 -139.6%  
Price / Book Value ratio x1.42.3 59.0%  
Dividend payout %029.6 0.0%   
Avg Mkt Cap Rs m7,07419,784 35.8%   
No. of employees `0002.8NA-   
Total wages/salary Rs m1,4491,221 118.7%   
Avg. sales/employee Rs Th1,874.1NM-  
Avg. wages/employee Rs Th527.0NM-  
Avg. net profit/employee Rs Th-407.7NM-  
INCOME DATA
Net Sales Rs m5,1548,459 60.9%  
Other income Rs m100394 25.4%   
Total revenues Rs m5,2548,852 59.3%   
Gross profit Rs m-7662,070 -37.0%  
Depreciation Rs m711249 285.4%   
Interest Rs m1,50331 4,846.8%   
Profit before tax Rs m-2,8812,184 -131.9%   
Minority Interest Rs m110-   
Prior Period Items Rs m-6-225 2.5%   
Extraordinary Inc (Exp) Rs m1,7710-   
Tax Rs m17606 2.8%   
Profit after tax Rs m-1,1211,353 -82.9%  
Gross profit margin %-14.924.5 -60.8%  
Effective tax rate %-0.627.7 -2.1%   
Net profit margin %-21.816.0 -136.0%  
BALANCE SHEET DATA
Current assets Rs m3,8104,355 87.5%   
Current liabilities Rs m8,3651,792 466.8%   
Net working cap to sales %-88.430.3 -291.6%  
Current ratio x0.52.4 18.7%  
Inventory Days Days15644 350.3%  
Debtors Days Days6725 272.6%  
Net fixed assets Rs m14,4803,025 478.7%   
Share capital Rs m61179 34.3%   
"Free" reserves Rs m9038,243 11.0%   
Net worth Rs m5,1278,453 60.7%   
Long term debt Rs m5,83211 54,501.9%   
Total assets Rs m19,43310,557 184.1%  
Interest coverage x-0.971.4 -1.3%   
Debt to equity ratio x1.10 89,855.0%  
Sales to assets ratio x0.30.8 33.1%   
Return on assets %2.013.1 15.0%  
Return on equity %-21.916.0 -136.6%  
Return on capital %3.623.5 15.5%  
Exports to sales %24.513.3 184.3%   
Imports to sales %10.23.3 304.6%   
Exports (fob) Rs m1,2641,126 112.3%   
Imports (cif) Rs m525283 185.6%   
Fx inflow Rs m1,5391,146 134.3%   
Fx outflow Rs m942355 265.1%   
Net fx Rs m597791 75.5%   
CASH FLOW
From Operations Rs m5991,485 40.4%  
From Investments Rs m-438-620 70.7%  
From Financial Activity Rs m-303-753 40.2%  
Net Cashflow Rs m-141113 -125.3%  

Share Holding

Indian Promoters % 74.5 68.9 108.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 4.7 12.8%  
FIIs % 1.3 7.5 17.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 19.0 124.2%  
Shareholders   10,259 23,730 43.2%  
Pledged promoter(s) holding % 35.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   PLETHICO PHARMA  BIOCON LTD  FULFORD INDIA  NATCO PHARMA  AJANTA PHARMA  

Compare PANACEA BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Aug 22, 2017 03:36 PM

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS